Skip to main content
Signal8

GSK plc (GSK) Form 6-K — Nov 20, 2026

$GSKForm 6-KFiled Nov 20, 2026, 10:25 AM ET0001654954-26-010027Original filing

GSK plc transferred 22,000,000 ordinary shares held in treasury to JPMorgan Chase Bank, N.A., its ADR depositary, to procure issuance of 11,000,000 ADRs to the GlaxoSmithKline (US) Trust on 20 November 2026. The ADRs will be used to satisfy awards under GSK's Deferred Annual Bonus Plan, Performance Share Plan and Share Value Plan, with the trustee paying $47.82 per ADR ($23.91 per ordinary share) funded by a GlaxoSmithKline LLC contribution. After the transfer, GSK holds 248,881,064 treasury shares with 4,067,451,066 ordinary shares in issue excluding treasury, leaving treasury voting rights at 6.12%.

Key figures

Adrs issued
11000000
Price per adr usd
47.82
Total voting rights
4067451066
Treasury shares held after
248881064
Treasury shares transferred
22000000
Price per ordinary share usd
23.91
Treasury voting rights percent
6.12
Ordinary shares in issue ex treasury
4067451066

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.